BMJ:呼吁遏制过度输血

2014-07-31 佚名 丁香园

牛津大学约翰拉德克利夫医院的 Hibbs 教授等认为,像“明智选择”和“过度医疗”这样的运动十分有意义,其鼓励医患沟通以实现明智的医疗选择。而对于开放性输血的应用亦应被重新思考,目前的临床应用过度强调了开放性输血的益处,而其风险却被低估。文章发表在 2014 年 7 月 22 日出版的 BMJ 杂志上。减少非恰当血液制品应用的倡导在血液制品有效应用中发挥了积极作用,例如,其使英国红细胞使用量在过去

牛津大学约翰拉德克利夫医院的 Hibbs 教授等认为,像“明智选择”和“过度医疗”这样的运动十分有意义,其鼓励医患沟通以实现明智的医疗选择。而对于开放性输血的应用亦应被重新思考,目前的临床应用过度强调了开放性输血的益处,而其风险却被低估。文章发表在 2014 年 7 月 22 日出版的 BMJ 杂志上。

减少非恰当血液制品应用的倡导在血液制品有效应用中发挥了积极作用,例如,其使英国红细胞使用量在过去 15 年中下降了 20%.然而,由于在实践过程中遇到了阻碍,这些作用十分有限,过度输血的现象仍然存在。Hibbs 教授表示,希望这些倡导可以和“过度医疗”等运动一起发挥出协同作用。

依据“明智选择”提出的 5 个关键问题,美国血库协会针对血液制品的应用提出了 5 项建议:在必需的血液外不多输额外的血液;对血流动力学稳定的缺铁性贫血不输红细胞;血液制品的应用不作为逆转华法林作用的常规方法;对状态稳定的患者不进行连续的血细胞计数检查;若患者血型不是 O 型 Rh 阴性,则 O 型 Rh 阴性血只用于血型未知的有生育能力妇女的急救。

以上这些建议旨在提示临床医生重新思考对开放性输血的常规应用,与此同时,鼓励患者提高意识,对医生的血液处方提出疑问。

Hibbs 教授认为,即使有明显的证据表明限制性输血的意义,也很难改变临床医生对开放性输血的常规应用。所以他希望,借着“明智选择”等运动所带来的文化转向势头,美国血库协会公布的 5 项建议能够促使患者和临床医生在输血之前进行更充分地思考,从而减少过度输血给患者带来的伤害和对医院资源的浪费。

原始出处:


Stephen P Hibbs, academic foundation doctor1, Michael F Murphy, professor of blood transfusion medicine1.Transfusing wisely.BMJ 2014; 349 doi: http://dx.doi.org/10.1136/bmj.g4701 (Published 22 July 2014)


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1847604, encodeId=5c86184e6048c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu May 28 10:52:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11634, encodeId=1f2a1163469, content=实事求是, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=111.193.167.94, createdTime=Sun Sep 14 03:40:00 CST 2014, time=2014-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10905, encodeId=64361090564, content=向外国学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=431f37155, createdName=lvjinglong, createdTime=Tue Aug 05 22:09:00 CST 2014, time=2014-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259635, encodeId=c9e41259635fa, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sat Aug 02 01:52:00 CST 2014, time=2014-08-02, status=1, ipAttribution=)]
    2015-05-28 gaoxiaoe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1847604, encodeId=5c86184e6048c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu May 28 10:52:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11634, encodeId=1f2a1163469, content=实事求是, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=111.193.167.94, createdTime=Sun Sep 14 03:40:00 CST 2014, time=2014-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10905, encodeId=64361090564, content=向外国学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=431f37155, createdName=lvjinglong, createdTime=Tue Aug 05 22:09:00 CST 2014, time=2014-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259635, encodeId=c9e41259635fa, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sat Aug 02 01:52:00 CST 2014, time=2014-08-02, status=1, ipAttribution=)]
    2014-09-14 111.193.167.94

    实事求是

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1847604, encodeId=5c86184e6048c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu May 28 10:52:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11634, encodeId=1f2a1163469, content=实事求是, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=111.193.167.94, createdTime=Sun Sep 14 03:40:00 CST 2014, time=2014-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10905, encodeId=64361090564, content=向外国学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=431f37155, createdName=lvjinglong, createdTime=Tue Aug 05 22:09:00 CST 2014, time=2014-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259635, encodeId=c9e41259635fa, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sat Aug 02 01:52:00 CST 2014, time=2014-08-02, status=1, ipAttribution=)]
    2014-08-05 lvjinglong

    向外国学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1847604, encodeId=5c86184e6048c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu May 28 10:52:00 CST 2015, time=2015-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=11634, encodeId=1f2a1163469, content=实事求是, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=111.193.167.94, createdTime=Sun Sep 14 03:40:00 CST 2014, time=2014-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=10905, encodeId=64361090564, content=向外国学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=431f37155, createdName=lvjinglong, createdTime=Tue Aug 05 22:09:00 CST 2014, time=2014-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1259635, encodeId=c9e41259635fa, content=<a href='/topic/show?id=569c9382389' target=_blank style='color:#2F92EE;'>#输血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93823, encryptionId=569c9382389, topicName=输血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec9955, createdName=windight, createdTime=Sat Aug 02 01:52:00 CST 2014, time=2014-08-02, status=1, ipAttribution=)]
    2014-08-02 windight

相关资讯

吴一龙:肿瘤诊疗的“明智选择”

从2010年开始,一项被称为“明智选择”的医学建议正在受到越来越多的关注。也得到越来越多医学专业学会的反应,甚至有人认为,这是21世纪临床思维的一场变革,势必广泛影响临床实践直至医疗保健体系的重构。 1、什么是“明智选择”? 在本世纪刚翻开它新的一页的2002年,美国内科专家委员会(American Board of Intemal Medicine.ABIM)发表了它的“医生